InvivoGen   Report issue

For profit Phase 1 Phase 2
Founded: San Diego CA United States (1997)

Organization Overview

First Clinical Trial
2010
NCT01274455
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

CAYLA-INVIVOGEN | InvivoGen Therapeutics